DK0894143T3 - VMP-lignende sekvenser af patogenisk borrelia - Google Patents

VMP-lignende sekvenser af patogenisk borrelia

Info

Publication number: DK0894143T3
Authority: DK; Denmark
Prior art keywords: polypeptides; sequences; dna; acid sequences; vmp
Prior art date: 1996-02-21

Application number

DK97914794T

Other languages

English (en)

Other versions

DK0894143T4 (da

Inventor

Steven J Norris

Jing-Ren Zhang

John M Hardham

Jerrilyn K Howell

Alan G Barbour

George M Weinstock

Original Assignee

Univ Texas

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1996-02-21

Filing date

1997-02-20

Publication date

2005-09-19

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=21753038&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0894143(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1997-02-20 Application filed by Univ Texas filed Critical Univ Texas

2005-09-19 Application granted granted Critical

2005-09-19 Publication of DK0894143T3 publication Critical patent/DK0894143T3/da

2012-07-16 Publication of DK0894143T4 publication Critical patent/DK0894143T4/da

Links

208000016604 Lyme disease Diseases 0.000 title abstract 3
241000589968 Borrelia Species 0.000 title abstract 2
230000001717 pathogenic effect Effects 0.000 title abstract 2
229920001184 polypeptide Polymers 0.000 abstract 4
102000004196 processed proteins & peptides Human genes 0.000 abstract 4
108090000765 processed proteins & peptides Proteins 0.000 abstract 4
108020004414 DNA Proteins 0.000 abstract 2
108091028043 Nucleic acid sequence Proteins 0.000 abstract 2
125000003275 alpha amino acid group Chemical group 0.000 abstract 2
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
238000001514 detection method Methods 0.000 abstract 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
208000035475 disorder Diseases 0.000 abstract 1
238000009169 immunotherapy Methods 0.000 abstract 1
238000000034 method Methods 0.000 abstract 1
150000007523 nucleic acids Chemical group 0.000 abstract 1
208000007865 relapsing fever Diseases 0.000 abstract 1
239000000523 sample Substances 0.000 abstract 1
239000013598 vector Substances 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
- C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
- C07K16/1207—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/44—Antibodies bound to carriers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/008—Peptides; Proteins
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B7/00—Recording or reproducing by optical means, e.g. recording using a thermal beam of optical radiation by modifying optical properties or the physical structure, reproducing using an optical beam at lower power by sensing optical properties; Record carriers therefor
- G11B7/007—Arrangement of the information on the record carrier, e.g. form of tracks, actual track shape, e.g. wobbled, or cross-section, e.g. v-shaped; Sequential information structures, e.g. sectoring or header formats within a track
- G11B7/00772—Arrangement of the information on the record carrier, e.g. form of tracks, actual track shape, e.g. wobbled, or cross-section, e.g. v-shaped; Sequential information structures, e.g. sectoring or header formats within a track on record carriers storing information in the form of optical interference patterns, e.g. holograms
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B7/00—Recording or reproducing by optical means, e.g. recording using a thermal beam of optical radiation by modifying optical properties or the physical structure, reproducing using an optical beam at lower power by sensing optical properties; Record carriers therefor
- G11B7/12—Heads, e.g. forming of the optical beam spot or modulation of the optical beam
- G11B7/125—Optical beam sources therefor, e.g. laser control circuitry specially adapted for optical storage devices; Modulators, e.g. means for controlling the size or intensity of optical spots or optical traces
- G11B7/128—Modulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/05—Isotopically modified compounds, e.g. labelled
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/11—Compounds covalently bound to a solid support
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
- G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
- G—PHYSICS
- G11—INFORMATION STORAGE
- G11B—INFORMATION STORAGE BASED ON RELATIVE MOVEMENT BETWEEN RECORD CARRIER AND TRANSDUCER
- G11B7/00—Recording or reproducing by optical means, e.g. recording using a thermal beam of optical radiation by modifying optical properties or the physical structure, reproducing using an optical beam at lower power by sensing optical properties; Record carriers therefor
- G11B7/004—Recording, reproducing or erasing methods; Read, write or erase circuits therefor
- G11B7/0065—Recording, reproducing or erasing by using optical interference patterns, e.g. holograms
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Genetics & Genomics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biophysics (AREA)
Hematology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Optics & Photonics (AREA)
Microbiology (AREA)
Cell Biology (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Food Science & Technology (AREA)
Biotechnology (AREA)
Virology (AREA)
Gastroenterology & Hepatology (AREA)
Tropical Medicine & Parasitology (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cephalosporin Compounds (AREA)

DK97914794.9T 1996-02-21 1997-02-20 VMP-lignende sekvenser af patogenisk Borrelia DK0894143T4 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US1202896P	1996-02-21	1996-02-21
PCT/US1997/002952 WO1997031123A1 (en)	1996-02-21	1997-02-20	Vmp-like sequences of pathogenic borrelia

Publications (2)

Publication Number	Publication Date
DK0894143T3 true DK0894143T3 (da)	2005-09-19
DK0894143T4 DK0894143T4 (da)	2012-07-16

Family

ID=21753038

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK97914794.9T DK0894143T4 (da)	1996-02-21	1997-02-20	VMP-lignende sekvenser af patogenisk Borrelia

Country Status (7)

Country	Link
US (11)	US6437116B1 (da)
EP (2)	EP1589109B1 (da)
AT (1)	ATE301716T1 (da)
AU (1)	AU2191597A (da)
DE (1)	DE69733944T3 (da)
DK (1)	DK0894143T4 (da)
WO (1)	WO1997031123A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6437116B1 (en) *	1996-02-21	2002-08-20	Board Of Regents, The University Of Texas System	VMP-like sequences of pathogenic borrelia
ES2270523T3 (es) *	1997-06-30	2007-04-01	The Administrators Of The Tulane Educational Fund	Antigenos de superficie y proteinas utiles en composiciones para la diagnosis y prevencion de la enfermedad de lyme.
US6475492B1 (en) *	1999-04-28	2002-11-05	The Administrators Of The Tulane Educational Fund	Peptides and assays for the diagnosis of lyme disease
WO2003078575A2 (en) *	2002-03-11	2003-09-25	The Johns Hopkins University	Molecular switches and methods for making and using the same
US7847084B2 (en)	2002-12-20	2010-12-07	Board Of Regents, The University Of Texas System	VMP-like sequences of pathogenic Borrelia species and strains
US7149014B2 (en) *	2003-04-18	2006-12-12	California Institute Of Technology	Holographic memory using beam steering
US20040219099A1 (en) *	2003-05-02	2004-11-04	Jasbir Sandhu	Method for the treatment of tumors
US20040220085A1 (en) *	2003-05-02	2004-11-04	Jasbir Sandhu	Compositions for nucleic acid delivery
JP2007518199A (ja) *	2004-01-13	2007-07-05	ニューヨーク・ユニバーシティ	多重線形独立要素分析を使用した画像認識の方法、システム、記憶媒体、及びデータ構造
EP1718753A4 (en)	2004-01-28	2009-01-21	Univ Johns Hopkins	METHOD FOR THE PRODUCTION AND USE OF MOLECULAR SWITCHES CONTRIBUTING TO CIRCULAR PERMUTATION
WO2007133623A2 (en) *	2006-05-10	2007-11-22	Biopeptides Corporation	Peptide diagnostic agent for lyme disease
KR101336248B1 (ko) *	2007-02-22	2013-12-03	삼성전자주식회사	홀로그래픽 저장 매체에의 데이터 기록 장치 및 방법
KR20100063048A (ko) *	2007-07-31	2010-06-10	더 존스 홉킨스 유니버시티	신생물성 또는 감염성 장애의 면역예방 또는 면역치료를 위한 폴리펩티드-핵산 접합체
US8313915B2 (en) *	2009-01-21	2012-11-20	Gundersen Lutheran Medical Foundation, Inc.	Early detection of canine lyme disease by specific peptides and antibodies
WO2011063003A2 (en)	2009-11-17	2011-05-26	Abaxis, Inc.	Peptides and methods for the detection of lyme disease antibodies
EP2545382B1 (en) *	2010-03-10	2017-09-20	The United States of America, as represented by The Secretary, Department of Health and Human Services	Compositions and methods for screening for lyme disease
US8624338B2 (en) *	2011-05-05	2014-01-07	Taiwan Semiconductor Manufacturing Company, Ltd.	Multi-nanometer-projection apparatus for lithography, oxidation, inspection, and measurement
US10100092B2 (en)	2011-11-03	2018-10-16	Vca, Inc.	Compositions and methods to detect various infectious organisms
US8758772B2 (en)	2011-11-04	2014-06-24	Abaxis, Inc.	Peptides and methods for the detection of lyme disease antibodies
US11061028B2 (en)	2014-09-24	2021-07-13	Defined Diagnostics, Llc	Compositions and methods for the diagnosis of lyme disease
CN108351355A (zh)	2015-08-27	2018-07-31	奎多公司	具有两个流体流动路径用于检测和区分两个或多个分析物的免疫分析测试设备
US10401358B1 (en)	2016-09-30	2019-09-03	Ross Southern Laboratories	Serodiagnosis of lyme disease by use of two recombinant proteins in ELISA
US11446654B2 (en)	2017-02-10	2022-09-20	Quidel Corporation	Substrate with channels for controlled fluid flow
US20200255889A1 (en) *	2017-09-25	2020-08-13	The Trustees Of Columbia University In The City Of New York	Serological assay for detection of exposure to and infection by tick-borne pathogens
EP4302087A1 (en) *	2021-03-02	2024-01-10	IDEXX Laboratories, Inc.	Biochemical probes attached to epoxy-based resins

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1202896A (en)	1916-03-14	1916-10-31	Frank C Ronk	Steam-radiator.
US4721617A (en) *	1986-08-14	1988-01-26	Regents Of The University Of Minnesota	Vaccine against lyme disease
US4801540A (en)	1986-10-17	1989-01-31	Calgene, Inc.	PG gene and its use in plants
US5246844A (en)	1991-10-22	1993-09-21	Board Of Regents, The University Of Texas System	Virulence associated proteins in borrelia burgdorferi (bb)
US5217874A (en)	1989-04-04	1993-06-08	Helena Laboratories Corporation	Fecal occult blood test product with positive and negative controls
US5385826A (en)	1989-04-21	1995-01-31	Gundersen Medical Foundation, Ltd.	Diagnostic assay for lyme disease
US5279938A (en)	1989-06-05	1994-01-18	The United States Of America As Represented By The Department Of Health And Human Services	Sensitive diagnostic test for lyme disease
DE4015911A1 (de)	1989-09-19	1991-03-28	Max Planck Gesellschaft	Impfstoff gegen die lyme-krankheit
US5187065A (en)	1989-12-22	1993-02-16	Schutzer Steven E	Method and materials for detecting lyme disease
US5217872A (en)	1990-02-27	1993-06-08	The United States Of America As Represented By The Department Of Health And Human Services	Method for detection of borrelia burgdorferi antigens
ATE142888T1 (de)	1990-03-05	1996-10-15	Us Health	Antigen-wirkende proteine von borrelia burgdorferi
CA2057536C (en) *	1990-12-21	1999-10-26	John J. Dunn	Cloning and expression of borrelia lipoproteins
US5436000A (en)	1991-01-11	1995-07-25	University Of Texas System	Flagella-less borrelia
US5155022A (en)	1991-02-08	1992-10-13	Becton, Dickinson And Company	Assay for lyme disease
US5283175A (en)	1991-04-15	1994-02-01	The Research Foundation Of State University Of New York	Genus-specific oligomers of Borrelia and methods of using same
US5324630A (en)	1991-06-28	1994-06-28	The Regents Of The University Of California	Methods and compositions for diagnosing lyme disease
US5304718A (en)	1992-02-03	1994-04-19	Research Corporation Technologies, Inc.	Cytoplasmic male sterile quinoa
US6437116B1 (en) *	1996-02-21	2002-08-20	Board Of Regents, The University Of Texas System	VMP-like sequences of pathogenic borrelia
DE19632862B4 (de)	1996-08-14	2006-08-03	Mikrogen Molekularbiologische Entwicklungs-Gmbh	Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
ES2270523T3 (es)	1997-06-30	2007-04-01	The Administrators Of The Tulane Educational Fund	Antigenos de superficie y proteinas utiles en composiciones para la diagnosis y prevencion de la enfermedad de lyme.
US6064586A (en) *	1998-12-31	2000-05-16	Siros Technologies, Inc.	Method for holographic data storage and retrieval
US6475492B1 (en)	1999-04-28	2002-11-05	The Administrators Of The Tulane Educational Fund	Peptides and assays for the diagnosis of lyme disease
US6958967B2 (en) *	2000-11-17	2005-10-25	Matsushita Electric Industrial Co., Ltd.	Holographic optical information recording/reproducing device
US6862120B2 (en) *	2001-03-22	2005-03-01	Pioneer Corporation	Hologram recording medium, hologram recording method and hologram recording and reproducing apparatus

1997
- 1997-02-20 US US09/125,619 patent/US6437116B1/en not_active Expired - Lifetime
- 1997-02-20 DE DE69733944T patent/DE69733944T3/de not_active Expired - Lifetime
- 1997-02-20 WO PCT/US1997/002952 patent/WO1997031123A1/en active IP Right Grant
- 1997-02-20 EP EP05010338.1A patent/EP1589109B1/en not_active Revoked
- 1997-02-20 AU AU21915/97A patent/AU2191597A/en not_active Abandoned
- 1997-02-20 AT AT97914794T patent/ATE301716T1/de active
- 1997-02-20 EP EP97914794A patent/EP0894143B2/en not_active Expired - Lifetime
- 1997-02-20 DK DK97914794.9T patent/DK0894143T4/da active
2002
- 2002-07-31 US US10/143,024 patent/US6740744B2/en not_active Expired - Lifetime
- 2002-08-16 US US10/222,162 patent/US6878816B2/en not_active Expired - Lifetime
- 2002-08-16 US US10/222,566 patent/US6719983B2/en not_active Expired - Lifetime
2004
- 2004-05-24 US US10/852,555 patent/US7135176B2/en not_active Expired - Fee Related
- 2004-09-28 US US10/952,555 patent/US20050176947A1/en not_active Abandoned
2006
- 2006-08-07 US US11/501,166 patent/US7785597B2/en not_active Expired - Fee Related
2010
- 2010-08-09 US US12/853,019 patent/US8071109B2/en not_active Expired - Fee Related
2011
- 2011-12-05 US US13/311,259 patent/US8354240B2/en not_active Expired - Fee Related
2013
- 2013-01-10 US US13/738,518 patent/US9212218B2/en not_active Expired - Fee Related
2015
- 2015-12-14 US US14/968,842 patent/US20160266112A1/en not_active Abandoned

Also Published As

Publication number	Publication date
DE69733944D1 (de)	2005-09-15
EP0894143A4 (en)	2001-06-13
WO1997031123A1 (en)	1997-08-28
EP0894143A1 (en)	1999-02-03
DE69733944T2 (de)	2006-04-13
US20030060618A1 (en)	2003-03-27
EP1589109A2 (en)	2005-10-26
EP1589109B1 (en)	2017-04-12
US9212218B2 (en)	2015-12-15
US6740744B2 (en)	2004-05-25
ATE301716T1 (de)	2005-08-15
US7135176B2 (en)	2006-11-14
US8354240B2 (en)	2013-01-15
US7785597B2 (en)	2010-08-31
US20040214225A1 (en)	2004-10-28
DE69733944T3 (de)	2012-07-26
US6437116B1 (en)	2002-08-20
AU2191597A (en)	1997-09-10
EP0894143B2 (en)	2012-04-18
US20160266112A1 (en)	2016-09-15
US20040044192A1 (en)	2004-03-04
US20050176947A1 (en)	2005-08-11
US6878816B2 (en)	2005-04-12
EP0894143B1 (en)	2005-08-10
DK0894143T4 (da)	2012-07-16
US8071109B2 (en)	2011-12-06
US20130245234A1 (en)	2013-09-19
US20070117970A1 (en)	2007-05-24
US20120122238A1 (en)	2012-05-17
US20030092903A1 (en)	2003-05-15
US6719983B2 (en)	2004-04-13
US20100317026A1 (en)	2010-12-16
EP1589109A3 (en)	2005-11-16

Publication	Publication Date	Title
DK0894143T3 (da)	2005-09-19	VMP-lignende sekvenser af patogenisk borrelia
CY1106885T1 (el)	2012-09-26	Θεραπευτικες χρησεις il-17-ομολογων πολυπεπτιδιων
ATE444361T1 (de)	2009-10-15	Il-17 und il-17r homologe polypeptide und deren therapeutische verwendungen
CY1111097T1 (el)	2015-06-11	Πρωτεϊνη δεσμευσης του υποδοχεα nogo
MX9606463A (es)	1997-12-31	Secuencias de nucleotido de las cepas pestivirus, polipeptidos codificados por estas secuencias y usos de los mismos para la diagnosis y prevencion de infecciones con pestivirus.
BR9912455A (pt)	2001-04-17	ácidos nucléicos codificadores de proteìnas envolvidas em transdução sensória
DK1386931T3 (da)	2006-09-04	Human neurotriminhomolog
ATE316577T1 (de)	2006-02-15	Das goodpasture-antigen bindende protein
WO2004058181A3 (en)	2005-04-21	Vmp-like sequences of pathogenic borrelia species and strains
ATE310810T1 (de)	2005-12-15	Polypeptid und dafür kodierendes nukeinsäure
ATE275581T1 (de)	2004-09-15	Protein das die überlebensrate der stäbchen- photorezeptor erhöht und nukleinsäure die dafür kodieren.
DK1241179T3 (da)	2006-12-04	Humant protein med in vitro antiproliferativ aktivitet.
ATE380864T1 (de)	2007-12-15	Menschliches prostasin-ähnliches protein und dafür kodierende nukleinsäure
ATE404585T1 (de)	2008-08-15	Menschliches synaptogyrin-ähnliches protein und dafür kodierende nukleinsäure
ATE405590T1 (de)	2008-09-15	Menschliches hcar-ähnliches protein und dafür kodierende nukleinsäure
DE69827532D1 (de)	2004-12-16	Polypeptide und dafür kodierende Nukleinsäure
DK1191101T3 (da)	2004-10-11	PRO241 polypeptider og nucleinsyre kodende herfor
DE69829417D1 (de)	2005-04-21	Polypeptide und dafür kodierende Nukleinsäure
DE69931282D1 (de)	2006-06-14	Nukleinsäure die in menschliche Tumoren vervielfältigt sind, und damit zusammenhängende Materiale und Verfahren
DK1249491T3 (da)	2006-01-16	Nucleinsyre, der opformeres i humane tumorer samt beslægtede materialer og fremgangsmåder
DE60038986D1 (de)	2008-07-03	Ausgeschiedene und Transmembranpolypeptide und dafür kodierende Nukleinsäure
DE69923092D1 (de)	2005-02-10	Nukleinsäure die in menschliche Tumoren vervielfältigt sind, und damit zusammenhängende Materiale und Verfahren